Literature DB >> 16720471

Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles.

Arnold J J Reuser1, Maarten R Drost.   

Abstract

UNLABELLED: Between 40 and 50 lysosomal storage disorders are known at present. Fine details of the pathogenic process involved are in general not known. This overview highlights the basic principles of lysosomal pathogenesis and the clinical consequences of defective genes involved in lysosomal functions. The subject is discussed in the context of the possibility of prevention and reversal of cellular and organ damage by enzyme replacement therapy. Also presented is a mechanical model for the muscle pathology observed in Pompe disease. Direct mechanical effects of the non-contractile inclusions - glycogen-loaded lysosomes - seem to be a key factor in the loss of force during both early and late stages of the disease.
CONCLUSION: Each lysosomal storage disorder and each patient with a given lysosomal disorder has unique molecular, pathological and clinical features. But, the order of pathological events is largely the same. Mutations in a gene cause lysosomal dysfunction which, in turn, results in cellular pathology affecting organ structure and function. Clinical symptoms are the ultimate manifestation. The reversibility of symptoms with enzyme replacement therapy will vary according to the disease, as well as the nature and stage of organ pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720471     DOI: 10.1080/08035320600618957

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  9 in total

Review 1.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

Review 2.  Clinical aspects of neuropathic lysosomal storage disorders.

Authors:  Laura Bannach Jardim; Maria Mercedes Villanueva; Carolina F Moura de Souza; Cristina B Oliveira Netto
Journal:  J Inherit Metab Dis       Date:  2010-05-21       Impact factor: 4.982

Review 3.  Consensus treatment recommendations for late-onset Pompe disease.

Authors:  Edward J Cupler; Kenneth I Berger; Robert T Leshner; Gil I Wolfe; Jay J Han; Richard J Barohn; John T Kissel
Journal:  Muscle Nerve       Date:  2011-12-15       Impact factor: 3.217

4.  Differential regulation of homocysteine transport in vascular endothelial and smooth muscle cells.

Authors:  Xiaohua Jiang; Fan Yang; Eugen Brailoiu; Hieronim Jakubowski; Nae J Dun; Andrew I Schafer; Xiaofeng Yang; William Durante; Hong Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09       Impact factor: 8.311

Review 5.  Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.

Authors:  Joanna Jakóbkiewicz-Banecka; Alicja Wegrzyn; Grzegorz Wegrzyn
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

6.  Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Authors:  Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng H Cheng; Lamya S Shihabuddin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

Review 7.  Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance.

Authors:  Koffi L Lakpa; Nabab Khan; Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  J Neuroimmune Pharmacol       Date:  2021-03-22       Impact factor: 4.147

8.  Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts.

Authors:  Monica Cardone; Caterina Porto; Antonietta Tarallo; Mariella Vicinanza; Barbara Rossi; Elena Polishchuk; Francesca Donaudy; Generoso Andria; Maria Antonietta De Matteis; Giancarlo Parenti
Journal:  Pathogenetics       Date:  2008-12-01

9.  Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement.

Authors:  Jasem Al-Hashel; Ismail Ismail
Journal:  Case Rep Neurol       Date:  2022-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.